{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:10:03Z","timestamp":1790698203960,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.antiviral.2008.01.152","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T16:39:26Z","timestamp":1205339966000},"page":"150-161","source":"Crossref","is-referenced-by-count":64,"title":["Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions"],"prefix":"10.1016","volume":"78","author":[{"given":"Daniel G.","family":"Bausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Sprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Jeffs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Boumandouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.152_bib1","first-page":"247","article-title":"Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO\/International Study Team","volume":"56","author":"Anon.","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2008.01.152_bib2","unstructured":"Anon., 2005. Outbreak of Marburg virus hemorrhagic fever\u2014Angola, October 1, 2004\u2013March 29, 2005. MMWR Morb Mortal Wkly Rep. 54, pp. 308\u2013309."},{"key":"10.1016\/j.antiviral.2008.01.152_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1009657006550","article-title":"Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?","volume":"5","author":"Baize","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.antiviral.2008.01.152_bib4","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib5","unstructured":"Bausch, D.G., 2001. Of Sickness Unknown: Death, and Health, in Africa. United Nations Chronicle 38, pp. 5\u201313."},{"key":"10.1016\/j.antiviral.2008.01.152_bib6","series-title":"Emerging Infectious Diseases","first-page":"133","article-title":"Ebola, Marburg, Lassa, and other hemorrhagic fevers","author":"Bausch","year":"2007"},{"key":"10.1016\/j.antiviral.2008.01.152_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/9781555816995.ch4","article-title":"Responding to epidemics of Ebola hemorrhagic fever: progress and lessons learned from recent outbreaks in Uganda, Gabon, and Congo","volume":"6","author":"Bausch","year":"2004","journal-title":"Emerg. Infect."},{"key":"10.1016\/j.antiviral.2008.01.152_bib8","series-title":"Physicians\u2019 Information and Education Resource","article-title":"Ebola and Marburg viruses","author":"Bausch","year":"2006"},{"key":"10.1016\/j.antiviral.2008.01.152_bib9","series-title":"Physicians\u2019 Information and Education Resource","article-title":"Ebola and Marburg viruses","author":"Bausch","year":"2007"},{"key":"10.1016\/j.antiviral.2008.01.152_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3201\/eid0912.030355","article-title":"Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo","volume":"9","author":"Bausch","year":"2003","journal-title":"Emerg. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib11","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1086\/520542","article-title":"Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient","volume":"196","author":"Bausch","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJMoa051465","article-title":"Marburg hemorrhagic fever associated with multiple genetic lineages of virus","volume":"355","author":"Bausch","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib13","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1086\/520545","article-title":"Assessment of the risk of ebola virus transmission from bodily fluids and fomites","volume":"196","author":"Bausch","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.152_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1365-3156.2002.00945.x","article-title":"Short communication: a cluster of Marburg virus disease involving an infant","volume":"7","author":"Borchert","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.antiviral.2008.01.152_bib16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2004.05.025","article-title":"Ebola and Marburg virus-like particles activate human myeloid dendritic cells","volume":"326","author":"Bosio","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.152_bib18","first-page":"218","article-title":"Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo","volume":"98","author":"Boumandouki","year":"2005","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1016\/j.antiviral.2008.01.152_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(00)00066-8","article-title":"Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-l-homocysteine hydrolase inhibitor","volume":"45","author":"Bray","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.152_bib20","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/379727","article-title":"Ebola hemorrhagic fever and septic shock","volume":"188","author":"Bray","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00005-0","article-title":"Experimental therapy of filovirus infections","volume":"54","author":"Bray","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.152_bib23","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/01.ta.0000235525.64176.01","article-title":"The resuscitative fluid you choose may potentiate bleeding","volume":"61","author":"Brummel-Ziedins","year":"2006","journal-title":"J. Trauma"},{"key":"10.1016\/j.antiviral.2008.01.152_bib24","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib26","series-title":"Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting","author":"CDC and WHO","year":"1998"},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib27","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1086\/520543","article-title":"Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment","volume":"196","author":"Colebunders","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib29","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1086\/514284","article-title":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Dowell","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib30","series-title":"Marburg Virus Disease","first-page":"42","article-title":"Clinical manifestations and mechanism of the haemorrhagic diathesis in Marburg virus disease","author":"Egbring","year":"1971"},{"key":"10.1016\/j.antiviral.2008.01.152_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","article-title":"A case of Ebola virus infection","volume":"2","author":"Emond","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.antiviral.2008.01.152_bib32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1128\/AAC.50.3.984-993.2006","article-title":"VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice","volume":"50","author":"Enterlein","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.152_bib33","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2008.01.152_bib34","first-page":"291","article-title":"Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy?","volume":"63","author":"Formenty","year":"2003","journal-title":"Med. Trop. (Mars.)"},{"key":"10.1016\/j.antiviral.2008.01.152_bib35","doi-asserted-by":"crossref","first-page":"S534","DOI":"10.1097\/01.CCM.0000145944.64532.53","article-title":"Recombinant human activated protein C in the treatment of severe sepsis: an evidence-based review","volume":"32","author":"Fourrier","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2008.01.152_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/bmj.4.5995.489","article-title":"Outbreak of Marburg virus disease in Johannesburg","volume":"4","author":"Gear","year":"1975","journal-title":"Br. Med. J."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib37","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1086\/520608","article-title":"Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2","volume":"196","author":"Geisbert","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.antiviral.2008.01.152_bib39","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.152_bib40","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","article-title":"Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference","volume":"193","author":"Geisbert","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib41","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/01913129809032253","article-title":"Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy","volume":"22","author":"Geisbert","year":"1998","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib43","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib44","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"20","key":"10.1016\/j.antiviral.2008.01.152_bib45","first-page":"24","article-title":"An uncertain defense. How do you test that a human Ebola vaccine works? You don\u2019t","volume":"291","author":"Gibbs","year":"2004","journal-title":"Sci. Am."},{"key":"10.1016\/j.antiviral.2008.01.152_bib46","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","article-title":"Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication","volume":"75","author":"Gupta","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1160\/TH05-03-0153","article-title":"The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates","volume":"94","author":"Hensley","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib48","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever","volume":"196","author":"Hensley","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2008.01.152_bib50","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3201\/eid0910.020493","article-title":"Cultural contexts of ebola in northern Uganda","volume":"9","author":"Hewlett","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib51","first-page":"230","article-title":"Medical anthropology and Ebola in Congo: cultural models and humanistic care","volume":"98","author":"Hewlett","year":"2005","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1016\/j.antiviral.2008.01.152_bib52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.molmed.2006.03.006","article-title":"Ebola virus: unravelling pathogenesis to combat a deadly disease","volume":"12","author":"Hoenen","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2008.01.152_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2008.01.152_bib54","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib55","first-page":"135","article-title":"Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses","volume":"11","author":"Jahrling","year":"1996","journal-title":"Arch. Virol. Suppl."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib56","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib57","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib58","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1086\/520548","article-title":"The M\u00e9decins Sans Fronti\u00e8res intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital","volume":"196","author":"Jeffs","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib59","first-page":"101","article-title":"Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya","volume":"11","author":"Johnson","year":"1996","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.antiviral.2008.01.152_bib60","series-title":"Proceedings of the Filoviruses: Recent Advances and Future Challenges","article-title":"The magic bullet: VSV vaccines and therapy","author":"Jones","year":"2006"},{"issue":"7","key":"10.1016\/j.antiviral.2008.01.152_bib61","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2008.01.152_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for field research on the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antivir. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib63","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/514321","article-title":"Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Ksiazek","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib64","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/514294","article-title":"Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections","volume":"179","author":"Kudoyarova-Zubavichene","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1473-3099(03)00584-X","article-title":"Ebola outbreak in the news","volume":"3","author":"Larkin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2249.2001.01517.x","article-title":"Early immune responses accompanying human asymptomatic Ebola infections","volume":"124","author":"Leroy","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib67","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/438575a","article-title":"Fruit bats as reservoirs of Ebola virus","volume":"438","author":"Leroy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.152_bib68","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(04)01103-X","article-title":"Pathogenesis of filoviral haemorrhagic fevers","volume":"4","author":"Mahanty","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib69","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib70","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/CVI.00162-06","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"Martin","year":"2006","journal-title":"Clin. Vac. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib71","series-title":"Marburg Virus Disease","article-title":"Marburg virus disease. Clinical syndrome","author":"Martini","year":"1971"},{"key":"10.1016\/j.antiviral.2008.01.152_bib72","first-page":"457","article-title":"A hitherto unknown infectious disease contracted from monkeys. \u201cMarburg-virus\u201d disease","volume":"13","author":"Martini","year":"1968","journal-title":"Ger. Med. Mon."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib73","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/514281","article-title":"Ecology of Marburg and Ebola viruses: speculations and directions for future research","volume":"179","author":"Monath","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib74","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International scientific and technical committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2008.01.152_bib75","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/514289","article-title":"Ebola hemorrhagic fever and pregnancy","volume":"179","author":"Mupapa","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib76","first-page":"104","article-title":"A case of a laboratory infection with Marburg fever (Russian)","author":"Nikiforov","year":"1994","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib77","doi-asserted-by":"crossref","first-page":"0062","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2008.01.152_bib78","first-page":"13","article-title":"Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections","author":"Parrino","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(77)92002-5","article-title":"Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire","volume":"1","author":"Pattyn","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.152_bib80","first-page":"726","article-title":"Overview of viral hemorrhagic fevers","volume":"vol. 1","author":"Peters","year":"2006"},{"key":"10.1016\/j.antiviral.2008.01.152_bib81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3201\/eid1001.030125","article-title":"Ecologic and geographic distribution of filovirus disease","volume":"10","author":"Peterson","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib82","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3201\/eid1012.040346","article-title":"Potential mammalian filovirus reservoirs","volume":"10","author":"Peterson","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib83","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1086\/520541","article-title":"Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species","volume":"196","author":"Pourrut","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib84","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib85","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2008.01.152_bib86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2007.10.001","article-title":"FDA perspective on antivirals against biothreats: communicate early and often","volume":"78","author":"Roberts","year":"2008","journal-title":"Antivir. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib87","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1086\/520613","article-title":"Blood chemistry measurements and d-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus","volume":"196","author":"Rollin","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib88","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels","volume":"78","author":"Sanchez","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.152_bib89","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI116329","article-title":"Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease","volume":"91","author":"Schnittler","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2008.01.152_bib90","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/bsp.2005.3.94","article-title":"Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006","volume":"3","author":"Schuler","year":"2005","journal-title":"Biosecur. Bioterror."},{"key":"10.1016\/j.antiviral.2008.01.152_bib91","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(82)91871-2","article-title":"Marburg-virus disease in Kenya","volume":"1","author":"Smith","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.01.152_bib92","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2007.12.008","article-title":"Oligonucleotide antiviral therapeutics: anti-sense and interference for highly pathogenic RNA viruses","volume":"78","author":"Spurgers","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.01.152_bib93","series-title":"Marburg Virus Disease","first-page":"10","article-title":"Clinical course and prognosis of Marburg virus (\u201cGreen Monkey\u201d) disease","author":"Stille","year":"1971"},{"key":"10.1016\/j.antiviral.2008.01.152_bib94","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.152_bib95","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.152_bib96","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3201\/eid1312.071115","article-title":"Studies of reservoir hosts for Marburg virus","volume":"13","author":"Swanepoel","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib97","first-page":"7","article-title":"Protective efficacy of neutralizing antibodies against Ebola virus infection","author":"Takada","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2008.01.152_bib98","series-title":"Marburg Virus Disease","first-page":"19","article-title":"Clinical picture of two patients infected by the Marburg vervet virus","author":"Todorovitch","year":"1971"},{"key":"10.1016\/j.antiviral.2008.01.152_bib99","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1371\/journal.pone.0000764","article-title":"Marburg virus infection detected in a common African bat","volume":"2","author":"Towner","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2008.01.152_bib100","first-page":"93","article-title":"Antisense treatments for biothreat agents","volume":"8","author":"Warfield","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2008.01.152_bib101","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.152_bib102","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.ppat.0020001","article-title":"Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers","volume":"2","author":"Warfield","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2008.01.152_bib103","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.152_bib104","first-page":"97","article-title":"Pathologic features of filovirus infections in humans","volume":"235","author":"Zaki","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:52:52Z","timestamp":1684284772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0166354208000466"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.152","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}